These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15948811)

  • 1. Gender and liver fibrosis in chronic hepatitis: the role of iron status.
    Rigamonti C; Andorno S; Maduli E; Capelli F; Boldorini R; Sartori M
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1445-51. PubMed ID: 15948811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
    Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C.
    Guyader D; Thirouard AS; Erdtmann L; Rakba N; Jacquelinet S; Danielou H; Perrin M; Jouanolle AM; Brissot P; Deugnier Y
    J Hepatol; 2007 Apr; 46(4):587-95. PubMed ID: 17156889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
    Tanaka H; El-Karef A; Kaito M; Kinoshita N; Fujita N; Horiike S; Watanabe S; Yoshida T; Adachi Y
    Liver Int; 2006 Apr; 26(3):311-8. PubMed ID: 16584393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C.
    Svirtlih N; Jevtovic D; Simonovic J; Delic D; Dokic L; Gvozdenovic E; Boricic I; Nesic Z; Neskovic G; Urban V
    Hepatogastroenterology; 2007 Dec; 54(80):2324-7. PubMed ID: 18265657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation.
    Toniutto P; Fabris C; Bortolotti N; Minisini R; Avellini C; Fumo E; Pirisi M
    J Hepatol; 2004 Aug; 41(2):307-11. PubMed ID: 15288481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
    J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
    Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
    Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases.
    Prati D; Maggioni M; Milani S; Cerino M; Cianciulli P; Coggi G; Forni GL; Magnano C; Meo A; Gramignoli R; Rebulla P; Fiorelli G; Cappellini MD;
    Haematologica; 2004 Oct; 89(10):1179-86. PubMed ID: 15477201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
    Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN
    J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.